The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
Psychedelic therapy isn’t just about the drug; it’s about the dose, too. Here's why the overlooked middle ground may matter more than we think.
The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results